ABSTRACT. Control of maternofetal calcium transfer across the in situ perfused rat placenta at day 21 of gestation (term 23 d) was investigated in both intact fetuses and those parathyroidectomized by decapitation on day 19. Decapitation resulted in significant fetal hypocalcemia. Injection of fetuses subcutaneously through the uterine wall with 0.43 ~g bovine (b) PTH(1-84), 20 ng 1,25(OH),D3 or 10 FL of the appropriate diluent resulted 2 h later in a raised fetal blood ionized Ca concentration only with bPTH(1-84) in both normal and decapitated fetuses. Fetal decapitation caused a significant ( p < 0.001) fall in the clearance of 45Ca across the placenta (KmP5Ca), which was significantly ( p < 0.05) reversed after fetal bPTH(1-84) and 1,25 dihydroxy vitamin D3 (1,25(0H)2 D3) injection, but not back to normal levels. There was no effect of either hormone on K,P5Ca in placentas from intact fetuses, or on KmfSICr-EDTA (used as an extracellular marker) in either group. When 4 ng/mL r[Nle8321,Ty?4] PTH(1-34), 50 pg/mL 1,25(OH),D3 or the appropriate diluent was perfused through placentas the only response observed was a significant (p < 0.05) increase in KmP5Ca with 1,25(OH),D3 perfusion in placentas from decapitated fetuses, KmfSICr-EDTA being unchanged. Finally, perfusion with M forskolin (an activator of adenylate cyclase) stimulated KmP5Ca in placentas from both normal and decapitated fetuses. Although there was also some effect on KmfSICr-EDTA in the latter, there was none in the placentas from normal fetuses, and here the effect on KmP5Ca was dose dependent with an initial response at M. It is therefore suggested that fetal PTH and 1,25(0H),D3 may play a permissive role in the control of maternofetal calcium transfer and that other hormones which act via CAMP may be involved in the acute regulation of calcium transfer under normal conditions. (Pediatr Res 26: 109-115,1989) In the sheep there is evidence that prolactin may stimulate and calcitonin reduce net maternofetal calcium transfer (1, 2), and studies on fetally perfused sheep placenta suggests that PTHrP may stimulate calcium transfer (3). There have been few direct studies in other species (4) although fetal calcium homeostasis also appears to be autonomous in the rat. Thus PTH (5) and calcitonin (6) do not appear to cross the rat placenta and are presumably of fetal or placental (7, 8) origin, and the fetal parathyroids (9) and thyroid "C" cells (10) are active in utero.
JmfCa, unidirectional maternofetal flux
In the sheep there is evidence that prolactin may stimulate and calcitonin reduce net maternofetal calcium transfer (1, 2) , and studies on fetally perfused sheep placenta suggests that PTHrP may stimulate calcium transfer (3) . There have been few direct studies in other species (4) although fetal calcium homeostasis also appears to be autonomous in the rat. Thus PTH (5) and calcitonin (6) do not appear to cross the rat placenta and are presumably of fetal or placental (7, 8) origin, and the fetal parathyroids (9) and thyroid "C" cells (10) are active in utero. Fetal 1, 25 (OH)2D3 may be derived from the mother across the placenta (1 l), be produced by the placenta itself (l2), or by the fetal kidney (1 3) , although the fall in plasma 1 ,25(OH)2D3 concentration after bilateral nephrectomy of the sheep fetus (14) suggests thatjn this species the fetal kidney is the major source.
Stulc and Stulcova (1 5 ) have described a method for perfusing the fetal side of the rat placenta and demonstrated by this method active maternofetal calcium transport quantitatively similar to that found in vivo. We have also recently investigated the passive permeability of the rat placenta and found that not only is it similar per unit placental wt. to that of other haemochorial placentas but that it is not altered by fetal side perfusion (16) . The perfused rat placenta therefore seems a promising model with which to investigate fetal control of calcium transfer. In our study the effects of PTH and 1,25(OH),D3 have been studied both by injection into fetuses with subsequent perfusion of their placentas for measurement of calcium transfer and in other experiments by directly perfusing the hormones through the placentas. We have also investigated whether forskolin, a stimulator of adenylate cyclase (17) , could alter calcium transfer when perfused through the placenta. Experiments with all three agents, PTH, 1,25(OH)2D3, and forskolin have been carried out both with normal fetuses and with those which have been previously decapitated (18) as a means of removing the fetal parathyroids and lowering fetal plasma calcium concentration.
MATERIALS AND METHODS
Animals and General Procedures. Two groups of female pregnant Sprague-Dawley rats (Charles River, Manston, Kent, England) were used for all experiments described (females were left overnight with a male and if vaginal plugs were found in the morning then this was designated day 1 of gestation; term 23 d). One group of animals was left to develop as normal until d 21 of gestation when perfusions were carried out. In the other group fetal decapitation was canied out by the method of Jost (1 8) on d 19 of gestation. These rats were briefly anaesthetised with ether and the uterus was exposed at laparotomy. Heads of alternate fetuses were delivered through a loose purse string suture previ-ously placed in the uterus and the loop was then tightened so as to simultaneously sever the head and close the uterus. The abdomen was then closed and the animal allowed to recover.
For perfusion on d 21 of gestation both control and previously fetally decapitated rats were anaesthetized intraperitoneally with 110 mg/kg sodium thiobutabarbital (Inactin, BYK Gulden, Hamburg, FRG). Animals were maintained with maternal rectal temperatures close to 37°C throughout the experiments using a heated pad and warm dissection lamp; in the first group of studies (experiment 1, with bPTH(1-84)) perfused before the importance of close temperature control was established, temperature control was less accurate and rectal temperatures in similarly studied animals ranged from 34-37°C. The maternal carotid artery and jugular vein were catheterized, the uterus opened and immediately fetal blood was taken by axial incision for measurement of ionized calcium using a Radiometer ICA 1 (Radiometer, Copenhagen; corrected to pH 7.4). Maternal blood was also taken at the end of each experiment for measurement of Mica. Placentas were then perfused via the umbilical artery and vein (there is only one vein in the rat) using the method of Stulc and Stulcovi (1 5) as previously detailed (I 6). The perfusate was a modified Krebs Ringer solution containing (mM) NaCl (1 I%), KC1 (4.7), NaHC03 (24.9), CaC12-2H20 (1.25), KH2P04 (1.18), MgS04-7 H 2 0 (1.18), glucose (1 I), and 3.5% dextran (40,000 mol wt; Sigma Chemical Co., Poole, Dorset, England), warmed to 37"C, and perfused at a rate of 0.5 mL/min; venous eMuent was collected at 4-min intervals after a single passage through theplacenta. 45Ca (0.37-1.5 GBq/mg calcium) and "Cr-EDTA (37-74 MBq/mg chromium; used as a diffusional marker) (Amersham International plc, Bucks., England) were injected into the maternal jugular venous catheter at time zero (approximately 5 min after the start of perfusion) and maternal carotid blood samples (0.5 mL) were taken throughout the experiment for radioactive counting. 45Ca activity was measured using a Packard 2000Ca (Packard Instrument Co., Downers Grove, IL) with channels set to exclude 51Cr counts. 51Cr was counted using a Packard 800C 7-counter. Samples of perfusate were similarly analyzed for both 45Ca and "Cr. The criteria for a successful preparation were defined as: perfusate recovery 95-100% by wt, maternal blood pressure of more than 8.6 kPa (65 mm Hg), perfusion pressure less than 5.6 kPa (40 mm Hg) and the placenta was bright red and uniformly perfused at the end of the experiment. There were no exclusions on this basis in the present series of experiments. Fetuses were weighed with the cord cut off after a brief blotting. Placentas were weighed after triming free of membranes and brief blotting.
KmPSCa and Km?'Cr-EDTA were defined as:
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[A1 W where [v] is the concentration of radioisotope in fetal venous outflow, Q is the perfusion flow rate, [A] is the concentration of tracer in the maternal arterial blood (extrapolated from the graph of isotope decay in the maternal blood, taken at the mid-time point of each perfusate collection) and W is the wet wt of the placenta. Kmf was taken to have achieved a steady state when there was no significant rise in its calculated value between adjacent control collection periods.
Experiments. Fetal injection with bPTH(1-84) and 1,25(OH)2 D3. After anaesthesia and uterus exposure on d 21, intact and decapitated fetuses were injected s.c. into the back of the fetal body through the uterine wall, with 1) 1.0 IU(0.43pg) bPTH(1-84) (National Institute for Biological Standards, London, England) in a 1 .O% sodium acetate and 0.1 % BSA (Sigma, protease free, 7906) solution, made up to pH 4 with glacial acetic acid, 2) 20 ng 1,25(OH)2D3 (Roche Products, Welwyn Garden City, England) in a 1:100 95% alcohol/0.9% saline solution, or 3) 10 pL of the appropriate diluent (i.e., either of the above solutions without hormone). The animals were then maintained anaesthetized and warm for 2 h after which the FiCa was measured and placentas perfused. KmP5Ca and Kmf5'Cr-EDTA were measured as described above. A crude measure of bPTH Belmont, CA) which is reported to be more stable and less prone to oxidative degradation than bPTH( 1-84) ( 19) in 1 : 10 diluent/ Krebs (1.0% sodium acetate, 0.1% BSA (Sigma, protease free A4378) at pH 4), 2) 50 pg/mL 1,25(OH)2D3 (Roche Products) in a 1: 100 95% alcohol/0.9% saline solution plus 0.2% proteasefree bovine albumin, or 3 ) the appropriate diluent, were introduced into the perfusate (via a side arm in the perfusion tubing close to the placenta using an infusion pump at a rate of 0.052 mL/min) for another 40 min. BSA (0.1%, protease free) was added to the Krebs Ringer in these experiments and the perfusion tubing primed with this solution for 10-15 min before the start of placental perfusion with the aim of albumin acting as a carrier molecule and preventing the hormones sticking to the tubing. For perfusion with 1,25(OH)2D3 a higher concentration of BSA (0.3%), was added to the perfusate in order to solubilize 1,25(OH)2D3 and to act as a carrier in the absence of vitamin D binding protein (20) .
As there was a lag time of approximately 5 min before hormone or diluent reached the umbilical artery, the next two perfusate collections of this period were not analyzed in either group, after which eight 4-min collections were made and data were expressed as the percentage change in K,f (with hormone or diluent) from the mean Kmf of the two control collection periods. A measure of r[Nle8,21,Tyr34]PTH(1-34) bioactivity was obtained by injecting 4 ng into intact rat fetuses and measuring FiCa 2 h later.
Placental perjiusion with forskolin. Placentas from both intact and decapitated fetuses were perfused and two 4-min control perfusate collections were made at 4-8 and 8-12 min after radioisotope injection. Then either 1)
M forskolin (Calbiochem, Behring Diagnostics, Cambridge Bioscience, England) in a 1: 10 95% alcohol/0.9% saline solution, or 2) 1: 10 95% alcohol/ 0.9% saline solution alone, were introduced into the perfusate via the side-arm as in experiment 2. The final concentration of forskolin in the perfusate as it entered the umbilical artery was M. Again, because of the lag time between switching on the side-arm infusion pump and drug or diluent actually entering the umbilical artery the next two perfusate collections were not analyzed. The next five 4-min collections were then taken for radioisotope analysis. Data are expressed as the percentage change in Kmf (with M forskolin or diluent) from the mean Kmf of the two control collection periods. This investigation was extended in placentas from intact fetuses only, by perfusion with M, M and M forskolin (final concentrations).
Statistics. Data are shown in all cases as the mean + the SEM and normality of distribution has been confirmed. Hence, statistical comparisons have been made using the Student' t test, paired or unpaired as appropriate or ANOVA and Duncan's multiple range test. Individual experimental animals were informally randomized to active agent or diluent in the various experimental groups by selecting the experimental protocol before the animal was brought to the laboratory.
RESULTS
Fetal and placental wt. In this series KmPSCa was again lower in placentas from decapitated compared with intact fetuses ( p < 0.001) but perfusion with r[Nle8,2',Tyr34]PTH(1-34) had no significant effect on KmP5Ca or KmfSICr-EDTA across placentas from either group. The perfusion of placentas from intact fetuses with 1 ,25(OH)2D3 also had no significant effect on either K,,,fSICr-EDTA or KmP5Ca.
In the group of animals with decapitated fetuses chosen (at random) to receive 1,25(OH)J& or its diluent, KmP5Ca was again lower than with intact fetuses ( p < 0.001) and KmfSICr-EDTA was significantly higher ( p < 0.01). Unfortunately, there was also a difference between those chosen for subsequent administration of 1,25(OH)2D3 or diluent in the control values of Kmf5'Cr-EDTA, which were significantly higher ( p < 0.05) in the group that was to receive 1,25(OH)2D3 than in the group that was to receive diluent (not illustrated). The opposite was true for KmPSCa, with control values significantly ( p < 0.01) higher in the group to receive diluent (Fig. 2) . Nevertheless, the 1,25(OH)2D3 caused a significantly greater change from the control value of KmP5Ca as compared to diluent perfusion, whether measured as percent change (Fig. 2) or in absolute terms. Mean KmfSICr-EDTA rose as a function of time in both the 1,25(OH)2D3 perfusion group and its diluent control but there was no difference between the two. Figure 3 shows the effect on KmPSCa, of perfusion of placentas from intact fetuses with M forskolin or its diluent alone. There were no significant differences in Kmf for either tracer between the first and second control period, or between the two groups, i.e. those which were to receive M forskolin and those which were to receive saline diluent. Forskolin had no effect on KmfSICr-EDTA (data not shown), but significantly ( p < 0.01) increased KmP5Ca both above the control period values and when compared to the percentage change with saline diluent (Fig. 3) .
Placentalperjiusion with forskolin.
The data for placentas of previously decapitated fetuses are shown in Figures 4 A and 0.05) increased KmfS1Cr-EDTA (as compared to saline diluent), but only in two experimental collection periods (Fig. 4A) . Perfusion with saline diluent in these experiments did significantly ( p < 0.05) increase KmP5Ca above control values in the first three experimental collection periods; this may have been due to unsteady state as unlike any of the other control periods, the KmPSCa showed a significant(p < 0.0 1) increase between the first (4-8 min) and the second (8-12 min) control period. However, the increase in KmP5Ca seen with forskolin perfusion was still significantly (p < 0.05) greater than that with saline diluent in the three middle experimental collection periods (Fig. 4B) . Figures 5 A and B show dose response curves of placentas from intact fetuses for forskolin constructed by taking the maximum percentage change from control found in the five forskolinlsaline perfused collection periods of each experiment and plotting the mean of these for each dose. KmfSICr-EDTA was unaffected by forskolin perfusion at any dose when compared with saline (Fig. 5A) . The two highest concentrations, and M forskolin showed a significant ( p < 0.0 1) stimulation of K,PSCa above control levels as compared to saline diluent (Fig. 5B ).
DISCUSSION

Viability of preparation. Perfusion of the fetal circulation of
the rat placenta provides a simple means of measuring calcium transfer and of administering hormones to the fetal side, and in the rat (16) , unlike the guinea pig (21), permeability to hydrophilic nonelectrolytes does not alter with perfusion. Similarly Stulc and StulcovL (1 5) demonstrated that almost identical values for KmP5Ca across the intact and the perfused rat placenta and our Kmf values for 45Ca in placentas from normal fetuses are similar to theirs. Evidence for active calcium transfer during perfusion comes from the fact that cyanide can markedly reduce calcium transfer (1 5). Our findings reported here that KmPSCa is 20-to 30-fold higher than the Kmf for the extracellular marker 51Cr-EDTA, whereas their diffusion coefficients are only 2-to 3-fold different, are compatible with such a conclusion and the observation that KmP5Ca here is more than 2-fold that of 22Na (16) , an ion with a smaller diffusion radius, is also compatible with active calcium transfer.
Use of K,,,J Ideally we would like to know the effect of hormonal interventions on both the affinity and the maximum velocity of the rate limiting element of the calcium active transport process (22) . Such a kinetic analysis would require a design in which maternal plasma calcium could be easily manipulated; impossible with an intact maternal circulation. However, as net transplacental calcium flux is almost equal to JmCa in the rat (1 5), net calcium accretion will depend on JmCa which will be a linear function of KmP5Ca, provided that flow limitation is unimportant and that maternal plasma calcium concentration is constant (22) . This latter requirement was rendered invalid in one series of experiments by the unexpected observation that MiCa was significantly higher when the fetus had received a bPTH(1-84) injection. [Most reports in the literature suggest that PTH does not cross the placenta, at least from mother to fetus (5), although such impermeability is unlikely to be an all or none phenomenon. Our experiments suggest that either enough PTH can cross the placenta from fetus to mother to have an effect or that PTH pe;haps stimulates increased synthesis by the fetal kidneys and placenta of 1,25(OH)2D3, which crosses to the mother and causes a rise in Mica (23) .] However, bPTH(1-84) increased calculated KmP5Ca and an increase in MiCa could be predicted to reduce KmPSCa in the absence of any change in placental calcium transfer kinetics. If anything, we will have underestimated the effect of bPTH(1-84) on the placental calcium transport mechanism.
Effect of decapitation.
Although fetal decapitation is a gross surgical intervention with a high failure rate in terms of fetal death in utero and sometimes maternal loss, it can result in live fetuses which are hypocalcemic and whose plasma calcium may be returned to normal by PTH injection, as shown here and previously (24) . Due to the substantial difference between decapitated and control fetuses we do not place great reliance on direct comparison between these two groups as any effects may be due to surgery in general, rather than parathyroidectomy alone. By contrast, the effects of injection or perfusion with specific drugs or hormones within each group, seem worthy of greater consideration.
Role of fetal PTH in control of placental Ca transfer. It has been suggested that fetal PTH plays a role in the generation of the "uphill" maternofetal calcium gradient (24, 25) , but it is not clear whether fetal PTH acts solely on fetal bone and kidney or whether it influences directly the putative placental calcium transporter.
In this study, the bioactivity of both molecules of PTH was confirmed before use although we have no measure of the actual amount of PTH in the fetal circulation after injection into fetuses. The doses used were chosen by their ability to raise FiCa several hours after injection into intact fetuses. bPTH(1-84) increased FiCa in both intact and decapitated fetuses. In intact fetuses this was probably due to a direct action on fetal bone rather than any placental effect and in decapitated fetuses may also have been partly due to a bone effect. It was only in the placentas from decapitated fetuses that bPTH(1-84) had a stimulatory effect on K,P5Ca, i.e. where the clearance was low to start with. However, even here, bPTH(1-84) still did not stimulate maternofetal calcium clearance back to normal. This either reflects a response to the gross fetal surgery or suggests only a permissive effect of this hormone on maternofetal calcium transfer in the rat. In these experiments, bPTH(1-84) could be acting either directly on the placental calcium transporter or via stimulation of the fetal kidney to synthesize 1,25(OH)2D3.
Perfusion with r[Nles,21,Tyr34]PTH(1-34) was carried out to investigate whether PTH was having a direct effect on the placenta, but it seemed to have no effect on K,PSCa in either preparation despite being effective in raising FiCa. Either the effect of bPTH(1-84) injection in decapitated fetuses on placental calcium transfer was solely due to increased production of 1,25(OH)2D3 or the course of action of PTH is too slow to show up in a 40-min perfusion period, or r[Nles22',Tyr34]PTH(1-34) is less active on the placenta than bPTH(1-84).
Role of fetal 1,25(OHj2D3 in control of placental Ca transfer. Other workers have reported fetal blood hypercalcemia in response to 1,25(OH)2D3 in sheep and rats (26, 27) . Chalon and Garel (27) injected approximately 2 ng 1,25(OH)2D3 into 19-d gestation rat fetuses and found an increase in FiCA by d 21, when compared to noninjected fetuses. The higher dose of 20 ng 1,25(OH)2D3 used here had no effect on FiCa after 2 h, but it could be that this time course was too short to observe a response. The effect of 1,25(OH)2D3 in this respect, was clearly quite different to that of bPTH(1-84) which did increase FiCa within 2 h.
The effect of fetally injected 1,25(OH)2D3 on K,P5Ca was similar to that of bPTH(1-84), in that there was stimulation, but only in placentas from decapitated fetuses. However, unlike r[Nle8,2',Tyr34]PTH(1-34), 1, 25 (OH)2D3 also stimulated maternofetal calcium clearance when perfused through the placentas of these decapitated fetuses. This provides some evidence for the idea that the in vivo effect of PTH is via 1,25(OH)2D3. The dose of 1,25(OH)2D3 used for perfusion experiments was close to the reported fetal plasma levels of 1,25(OH)2D3 (28) (54.7 pg/mL) and the suggestion of a placental effect of 1,25(OH)2D3 is also supported by the presence of 1,25(OH)2D3 receptors in the rat placenta (29) . 1,25(OH)2D3 (like bPTH 1-84) did not return calcium clearance back to normal levels in placentas of decapitated fetuses and, together with the lack of effect on placentas of intact fetuses, again suggests that the hormone may only have a permissive effect on placental transport.
Effects of forskolin in perfused rat placenta. Perfusion of forskolin through placenta of intact fetuses clearly increased KmP5Ca in a dose-dependent fashion. The probable EC50 between and lo-' M apparent in Figure 5B is consistent with the potency found for raising CAMP levels in other tissues (17) . The effect of forskolin in these placentas seemed to be specific to calcium transfer, as the clearance of 5'Cr-EDTA was not altered. This specificity was less clear in placentas from decapitated fetuses, in whom clearances of both "Cr-EDTA and 45Ca were increased. It could be that forskolin has nonspecific effects in the placenta, e.g. increasing blood flow (forskolin decreases placental vascular resistance in the rabbit) (30) or passive permeability, which are of greater importance to those placentas from decapitated fetwes. However, this requires further investigation. As with ~P T I I , ' -84) and 1,25(OH)2D3, forskolin did not increase KmP5Ca back to normal levels in placentas from decapitated fetuses, and this might suggest that surgery per se does affect the calcium transporter. It is clear that the effects of forskolin are quite different from those of PTH and 1,25(OH)2D3. In particular, the diterpene was able to stimulate maternofetal calcium transvort across la cent as from intact fetuses to supranormal levels. ~L i s therefore suggests that at least one further hormone (which forskolin mimics) acutely regulates placental calcium transfer in vivo; perhaps the recently reported PTHrP (3) or calcitonin (2) . An alternative possibility is a direct (independent of CAMP) action of forskolin on calcium channels in this system similar to its reported effect on voltage-gated K+ channels in a clonal pheochromocytoma cell line (3 1).
